Pumps, Pipes, and Filters: SGLT2 Inhibitors for Most Type 2 Diabetes? Pumps, Pipes, and Filters: SGLT2 Inhibitors for Most Type 2 Diabetes?

The new SGLT2 inhibitors should be considered for use in most patients with type 2 diabetes because of their benefits in reducing heart failure and renal disease, according to a new meta-analysis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news